FBT
FBT
About First Trust NYSE Arca Biotechnology Index Fund
The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund (ETF) designed with a clear purpose: to accurately reflect the price movements and income generated by the NYSE Arca Biotechnology Index. Its core objective is to closely match the performance of this benchmark index, before accounting for the fund's operational fees and expenses.
About First Trust NYSE Arca Biotechnology Index Fund
The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund (ETF) designed with a clear purpose: to accurately reflect the price movements and income generated by the NYSE Arca Biotechnology Index. Its core objective is to closely match the performance of this benchmark index, before accounting for the fund's operational fees and expenses.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 ILMN | Illumina, Inc. | 0.00% | 638.77K | $118.75M |
 INCY | Incyte Corporation | 0.00% | 804.07K | $89.85M |
 KRYS | Krystal Biotech, Inc. | 0.00% | 298.25K | $106.03M |
 ONC | BeOne Medicines AG | 0.00% | 249.46K | $74.17M |
 ADMA | ADMA Biologics, Inc. | 0.00% | 7.96M | $69.87M |
 REGN | Regeneron Pharmaceuticals, Inc. | 0.00% | 103.15K | $66.91M |
 RGEN | Repligen Corporation | 0.00% | 643.19K | $91.15M |
 UTHR | United Therapeutics Corporation | 0.00% | 135.11K | $70.78M |
 VCYT | Veracyte, Inc. | 0.00% | 2.48M | $139.70M |
 VRTX | Vertex Pharmaceuticals Incorporated | 0.00% | 177.06K | $83.18M |
 ALKS | Alkermes plc | 0.00% | 2.32M | $117.49M |
 ALNY | Alnylam Pharmaceuticals, Inc. | 0.00% | 239.79K | $67.57M |
 AMGN | Amgen Inc. | 0.00% | 220.08K | $77.60M |
 ARGX | argenx SE | 0.00% | 96.60K | $82.80M |
 ARWR | Arrowhead Pharmaceuticals, Inc. | 0.00% | 1.19M | $85.97M |
 EXEL | Exelixis, Inc. | 0.00% | 1.74M | $95.65M |
 AXSM | Axsome Therapeutics, Inc. | 0.00% | 433.71K | $96.85M |
 BIIB | Biogen Inc. | 0.00% | 446.59K | $91.31M |
 BMRN | BioMarin Pharmaceutical Inc. | 0.00% | 1.42M | $82.03M |
 BNTX | BioNTech SE | 0.00% | 808.87K | $71.27M |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
Ireland
Netherlands
Denmark
Switzerland
GermanySECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States Ireland Netherlands Denmark Switzerland GermanyHoldings (Top 20)
ILMN
Illumina, Inc.
INCY
Incyte Corporation
KRYS
Krystal Biotech, Inc.
ONC
BeOne Medicines AG
ADMA
ADMA Biologics, Inc.
REGN
Regeneron Pharmaceuticals, Inc.
RGEN
Repligen Corporation
UTHR
United Therapeutics Corporation
VCYT
Veracyte, Inc.
VRTX
Vertex Pharmaceuticals Incorporated
ALKS
Alkermes plc
ALNY
Alnylam Pharmaceuticals, Inc.
AMGN
Amgen Inc.
ARGX
argenx SE
ARWR
Arrowhead Pharmaceuticals, Inc.
EXEL
Exelixis, Inc.
AXSM
Axsome Therapeutics, Inc.
BIIB
Biogen Inc.
BMRN
BioMarin Pharmaceutical Inc.
BNTX
BioNTech SE